EDTA PROCEEDINGS

 

 

 

 

 

VOLUME 21

 

 

 

 

 

FLORENCE - 1984

 

 

 

 

 

 

 

 

 

 

INTRODUCTION

 

 

 

 

 

Cover [PDF]

 

 

 

 

 

Preface [PDF]

 

 

 

 

 

Contents [PDF]

 

 

 

 

 

Foreword [PDF]

 

 

 

 

 

Part I – STATISTICAL REPORTS

Page

 

 

 

 

 

Combined Report on Regular Dialysis and Transplantation in Europe,
XIV, 1983
   [PDF]

2

 

 

P Kramer, M Broyer, F P Brunner, H Brynger, S Challah, R Oulès,

G Rizzoni, N H Selwood, A J Wing, E A Balás

 

 

 

 

 

 

Combined Report on Regular Dialysis and Transplantation of Children
in Europe, XIII 1983
   [PDF]

69

 

 

G Rizzoni, M Broyer, F P Brunner, H Brynger, S Challah, P Kramer,

R Oulès, N H Selwood, A J Wing, E A Balás

 

 

       

Part II – GUEST LECTURES ON HAEMODIALYSIS

 

 

 

 

 

 

Dialysis membranes [PDF]

99

 

 

E F Leonard

 

 

       

The importance of water treatment in haemodialysis and haemofiltration [PDF]

111

 

 

P Keshaviah, D Luehmann

 

 

       

Part III  -  HAEMODIALYSIS: BIOCOMPATIBILITY

 

 

 

 

 

 

Acute pulmonary hypertension, leucopenia and hypoxia in early haemodialysis [PDF]

135

 

 

J F Walker, R M Lindsay, W J Sibbald, A L Linton

 

 

 

 

 

 

Effect of eosinophilia on the heterogeneity of the anticoagulant response to heparin
in haemodialysis patients
[PDF]

143

 

 

A Santoro, P Zucchelli, E Trombetti, E Degli Esposti, A Sturani, A Zuccalà,
C Chiarini, M Casadei-Maldini, A Mazzucca

 

 

 

 

 

 

Direct interaction between polymorphonuclear neutrophils and cuprophan
membranes in a plasma-free model of dialysis
[PDF]

150

 

 

C Tetta, A Jeantet, G Camussi, A Thea, L Gremo, P F Martini, R Ragni, A Vercellone

 

 

 

 

 

 

Effects of blood-dialyser interaction (sharm-dialysis) on haemodynamics
and oxygen tension in healthy man [PDF]

156

 

 

A Danielsson, U Freyschuss, J Bergström

 

 

 

 

 

 

Blood lines should be considered in studies of biocompatibility during acetate
haemodialysis
[PDF]

162

 

 

B Branger, R Oulès, D Treissède, J P Balducchi, F Michel, A Crastes de Paulet,
M Treille

 

 

 

 

 

 

The effect of dialysate temperature on haemodialysis leucopenia [PDF]

167

 

 

G Enia, C Catalano, F Pizzarelli, G Creazzo, F Zaccuri, A Mundo, D Iellamo, Q Maggiore

 

 

     

Anaphylactoid reactions during haemodialysis are due to ethylene oxide
hypersensitivity [PDF]

173

 

 

A J Nicholls, M M Platts

 

 

 

 

 

 

Part   IV - HAEMODIALYSIS: CARDIOVASCULAR STUDIES

 

 

 

 

 

 

Impaired regulation of β-adrenoceptors in patients on maintenance
haemodialysis
[PDF]

178

 

 

A E Daul, A M Khalifa, N Graven, O-E Brodde

 

 

 

 

 

 

Changes in left ventricular anatomy during haemodialysis, continuous
ambulatory peritoneal dialysis and after renal transplantation
[PDF]

185

 

 

A Deligiannis, E Paschalidou, G Sakellariou, V Vargemezis, P Geleris,
A Kontopoulos, M Papadimitriou

 

 

 

 

 

 

The role of endogenous opioids in the baroreflex dysfunction of dialysis patients [PDF]

190

 

 

C Zoccali, M Ciccarelli, F Mallamaci, Q Maggiore, M Stornello, E Valvo, L Scapellato

 

 

 

 

 

 

Absence of a beneficial haemodynamic effect of bicarbonate versus acetate
haemodialysis [PDF]

195

 

 

R Vanholder, M Piron, S Ringoir

 

 

 

 

 

 

Cardiovascular risk factors and cardiovascular death in haemodialysed
diabetic patients
[PDF]

202

 

 

C Strumpf, F Katz, A J Wing, E Ritz

 

 

 

 

 

 

Part V - HAEMODIALYSIS POSTERS I

 

 

 

 

 

 

Effect of dialysate buffer on potassium removal during haemodialysis [PDF]

209

 

 

A J Williams, J N Barnes, J Cunningham, F J Goodwin, F P Marsh

 

 

       

Favourable effects of bicarbonate dialysis on the body pool fo phosphate [PDF]

215

 

 

M Mastrangelo, S Rizzelli, V De Blasi, C Corlianò, L Alfonso, M Napoli,
A M Montinaro, M Aprile, P Patruno

 

 

 

 

 

 

Sodium acetate, an arterial vasodilator: haemodynamic characterisation in
normal dogs [PDF]

221

 

 

M A Saragoca, Angela M A Bessa, R A Mulinari, S A Draibe, A B Ribeiro, O L Ramos

 

 

 

 

 

 

Effects of dialysate sodium on the dopamine, adrenaline and noradrenaline
concentration in haemodialysis patients [PDF]

225

 

 

A Ksiażek, J Solski

 

 

       

The cardiovascular and metabolic effects of mixtures of acetate and succinate:
a potential improvement in dialysate solutions [PDF]

230

 

 

F M Gonzalez, P L Kirkendol, J E Pearson, E Reisin

 

 

 

 

 

 

Changes in body compartments on different types of haemodialysis [PDF]

235

 

 

M Garcia, M Carrera, C Piera, R Deulofeu, X Company, J Ma Pons, J Montoliu,
J Setoain, L Revert

 

 

       

Raised serum nickel concentrations in chronic renal failure [PDF]

241

 

 

M Drazniowsky, I S Parkinson, M K Ward, Susan M Channon, D N S Kerr

 

 

 

 

 

 

Changes in copper and zinc in chronic haemodialysis patients [PDF]

247

 

 

S Hosokawa, H Nishitani, T Imai, T Nishio, T Tomoyoshi, K Sawanishi

 

 

       

Myocardial studies in haemodialysis patients [PDF]

251

 

 

R Dudczak, L Fridrich, K Derfler, K Kletter, H Frischauf, L Marosi,
P Schmidt, J Zazgornik

 

 

       

Part   VI - HAEMODIALYSIS POSTERS II

 

 

 

 

 

 

Alternative vascular access in patients lacking veins for standart
arteriovenous fistulae
[PDF]

257

 

 

W P Reed, P D Light, J H Sandler, E Ramos

 

 

       

Initial experience with Hemasite vascular access device for maintenance
haemodialysis [PDF]

262

 

 

U Bonalumi, G A Simoni, D Friedman, E Borzone, F Griffanti-Bartoli

 

 

       

The Biocarbion® vascular access device (DiaTAB®) for haemodialysis [PDF]

267

 

 

P J H Smits, M J H Slooff, D H E Lichtendahl, G K v d Hem

 

 

 

 

 

 

Haemodialysis in dogs with a heparin coated hollow fibre dialyser [PDF]

270

 

 

L E Lins, P Olsson, M-B Hjelte, R Larsson, O Larm

 

 

       

Low molecular weight in haemodialysis and haemofiltration - comparison
with unfractioned heparin [PDF]

276

 

 

H Renaud, P Moriniere, J Dieval, Z Abdull-Massih, H Dkhissi, F Toutlemonde,
J Delobel, A Fournier

 

 

 

 

 

 

Haemodialysis with prostacyclin (Epoprostenol) alone [PDF]

281

 

 

P B Rylance, M P Gordge, H Ireland, D A Lane, M J Weston

 

 

       

Reduction of silicone particle release during haemodialysis [PDF]

287

 

 

J Bommer, E Pernicka, J Kessler, E Ritz

 

 

       

Carpal tunnel syndrome, shoulder pain and amyloid deposits in long-term
haemodialysis patients [PDF]

291

 

 

B Charra, E Calemard, M Uzan, J C Terrat, T Vanel, G Laurent

 

 

       

Reduction of osmotic haemolysis and anaemia by high dose vitamin E
supplementation in regular haemodialysis patients [PDF]

296

 

 

K Ono

 

 

       

Part   VII – HAEMODIALYSIS POSTERS III

 

 

 

 

 

 

Vaccination against hepatitis B in patients with renal insufficiency [PDF]

300

 

 

J Bommer, M Grussendorf, W Jilg, F Deinhardt, H-G Koch, G Darai,
G Bommer, M Rambausek, E Ritz

 

 

 

 

 

 

Platelet life span in uraemia [PDF]

306

 

 

H Tanaka, K Umimoto, N Izumi, K Nishimoto, T Maekawa, T Kishimoto, M Maekawa

 

 

 

 

 

 

Morbidity of patients with analgesic-associated nephropathy and end-stage
renal failure
[PDF]

311

 

 

A Schwarz, W Pommer, F Keller, G Kuehn-Freitag, G Offermann, M Molzahn

 

 

 

 

 

 

Herpes virus infection prevalence in regular haemodialysis patients -
a comparative evaluation of complement fixation, indirect
immunofluorescence and Elisa tests
[PDF]

317

 

 

F Scolari, N Manca, S Sandrini, L Cristinelli, E Prati, G Setti, S Savoldi,
A Turano, R Maiorca

 

 

 

 

 

 

Nitrate induced anaemia in home dialysis patients [PDF]

321

 

 

M Salvadori, F Martinelli, L Comparini, S Bandini, A Sodi

 

 

 

 

 

 

Nitrogen balance: an adequate treatment prescription index for children
on haemofiltration
[PDF]

326

 

 

M Giani, M Picca, A Saccaggi, R Galato, A Bettinelli, C Funari, R Rusconi,
L Ghio, A Edefonti

 

 

 

 

 

 

Visual function, blood pressure and blood glucose in diabetic patients
undergoing continuous ambulatory peritoneal dialysis
[PDF]

330

 

 

J Rottembourg, P Bellio, K Maiga, M Remaoun, F Rousselie, M Legrain

 

 

 

 

 

 

Computerised program to compare tolerance of dialysis patients to
different dialysis schedules
[PDF]

335

 

 

F Lonati, B Pea, A Castellani

 

 

 

 

 

 

Systolic timer intervals before and after haemodialysis [PDF]

348

 

 

J Braun, H Rupprecht, U Gessler

 

 

     

Part VIII – HAEMODIALYSIS: ALUMINIUM STUDIES

 

 

 

 

 

 

Gastrointestinal aluminium absorption: is it modulated by the iron-absorptive
mechanism?
[PDF]

354

 

 

J B Cannata, C Suarez Suarez, V Cuesta, R Rodriguez Roza, M T Allende,
J Herrera, J Perez Llanderal

 

 

 

 

 

 

Protein binding of aluminium in normal subjects and in patients with chronic
renal failure
[PDF]

360

 

 

H Rahman, S M Channon, A W Skillen, M K Ward, D N S Kerr

 

 

 

 

 

 

Desferrioxamine induced aluminium removal in haemodialysis [PDF]

366

 

 

J Bonal, J Montoliu, J Löpez Pedret, E Bergadä, L Andrew, M Bachs, L Revert

 

 

 

 

 

 

The desferrioxamine test predicts bone aluminium burden induced by Al(OH)з
in uraemic patients but not mild histological osteomalacia
[PDF]

371

 

 

A Fournier, P Fohrer, P Leflon, P Moriniere, M Tolani, G Lambrey, R Demontis,
J L Sebert, F Van Devyver, M Debroe

 

 

       

Iron removal by desferrioxamine during haemodialysis: in vitro studies [PDF]

377

 

 

D E Müller-Wiefel, U Vorderbrügge, K Schärer

 

 

 

 

 

 

Desferrioxamine treatment for aluminium and iron overload in uraemic patients
by haemodialysis or haemofiltration
[PDF]

382

 

 

C A Baldamus, H Schmidt, E-H Scheuermann, E Werner, J P Kaltwasser, W Schoeppe

 

 

 

 

 

 

Part IX – POSTERS ON HAEMODIALYSIS, ALUMINIUM STUDIES, OSTEODISTROPHY

   
       

Incorporation of aluminium and effect of removal in experimental osteomalacia
and fibro-osteoclasia [PDF]

387

 

 

T Hess, K Gautschi, H Jungbluth, U Binswanger

 

 

 

 

 

 

1αOH vitamin Dз increases plasma aluminium in haemodialysed patients
taking Al(OH)
з [PDF]

390

 

 

A Fournier, R Demontis, Y Tahiri, M Herve, Ph Moriniere, A Leflon,
Z Abdull-Massih, H Atik, S Benelmouffok

 

 

 

 

 

 

Red blood cells indices and aluminium toxicity in haemodialysis patients [PDF]

395

 

 

C Tielemans, L Kalima, F Collart, R Wens, J Smeyers-Verbeke,
D Verbeelen, M Dratwa (introduced by P Vereerstraeten)

 

 

 

 

 

 

Bone scan in haemodialysis patients: relation to hyperparathyroidism and
aluminium toxicity
[PDF]

399

 

 

C Tielemans, R Wens, F Collart, M Dratwa, J Smeyers-Verbeke, I Van Hooff,
G De Roy, P Bergmann, D Verbeelen (introduced by P Vereerstraeten)

 

 

 

 

 

 

The bone scan in patients with aluminium-associated bone disease [PDF]

403

 

 

J Botella, J L Gallego, J Fernandez-Fernandez, D Sanz-Guajardo,
A de Miguel, J Ramos, P Franco, R Enriques, C Sanz-Moreno

 

 

 

 

 

 

Assessing the benefit of changing aluminium hydroxide schedule on
anaemia and serum phosphorus control
[PDF]

410

 

 

J B Cannata, C Suarez Suarez, C Rodrigues Suarez, V Cuesta,
A Sanz-Medel, V Peral, J Herrera

 

 

 

 

 

 

Influence of biochemical and hormonal factors on the bone histomorphometric
features of uraemia patients
[PDF]

415

 

 

A Fournier, J L Sebert, P Fohrer, Ph Moriniere, G Lambrey, M A Herve,
P Leflon, J Gueris, M Garabedian

 

 

 

 

 

 

Fluoride metabolism and renal osteodystrophy in regular dialysis treatment [PDF]

421

 

 

J Erben, B Hájaková, M Pantůček, L Kubes

 

 

 

 

 

 

Evaluation of the intact hormone assay in the study of parathyroid
autograft function [PDF]

426

 

 

E C R Wijeyesinghe, A J Parnham, J R Farndon, R Wilkinson

 

 

 

 

 

 

Usefulness of 99mTc pyrophosphate bone scintigraphy in the survey
of dialysis osteodystrophy
[PDF]

431

 

 

J L Vanherweghem, A Schoutens, P Bergman, M Dhaene, M Goldman,
M Fuss, P Kinnaert

 

 

 

 

 

 

Bone mineral loss during centre and home haemodialysis. Influence of
vitamin D
metabolites and serum parathyroid hormone [PDF]

435

 

 

H Rickers, M Christensen, C Christiansen, P Rødbro

 

 

 

 

 

 

Part X – HAEMOFILTRATION AND HAEMODIAFILTRATION

 

 

 

 

 

 

Haemofiltration without substitution fluid [PDF]

441

 

 

G Civati, C Guastoni, U Teatini, A Perego, D Scorza, L Minetti

 

 

       

Performance characteristics of high flux haemodiafiltration [PDF]

447

 

 

B von Albertini, J H Miller, P W Gardner, J H Shinaberger

 

 

       

Standard methods for the microbiological assessment of electrolyte
solution prepared on line for haemofiltration
[PDF]

454

 

 

H U Mayr, F Stec, C M Mion

 

 

     

 

Phosphorus kinetics during haemodialysis and haemofiltration [PDF]

461

 

 

H Pogglitsch, W Petek, E Ziak, F Sterz, H Holzer

 

 

     

 

Concomitant removal of aluminium and iron by haemodialysis and
haemofiltration after desferrioxamine intravenous infusions
[PDF]

469

 

 

C Ciancioni, J L Poignet, C Naret, S Delons, Y Mauras, P Allain, N K Man

 

 

 

 

 

 

Part XI – SYMPOSIUM: OPTIMUM DIALYSIS TREATMENT FOR PATIENTS OVER 60
WITH PRIMARY RENAL DISEASE. SURVIVAL, CLINICAL RESULTS, QUALITY OF LIFE

   

 

 

 

 

Maintenance haemodialysis treatment in patients aged over 60 years.
Demographic profile, clinical aspects and outcome [PDF]

477

 

  C Jacobs, A Diallo, E A Bàlàs, M Nectoux, S Etienne    
       

Maintenance dialysis in the elderly. A review of 15 years' experience in
Languedoc-Roussilon
[PDF]

490

 

 

C Mion, R Oulès, B Canaud, G Mourad, A Slingeneyer, B Branger,
C Granolleras, B Al Sabadini, P Florence, R Chouzenoux, F Maurice,
R Issautier, J L Flavier, C Polito, F Saunier, L Marty, P Fontanier,
C Emond, H Ramtoolah, F de Cornelissen, G Huchard, H Fitte, R Boudet

 

 

       

Optimum dialysis treatment for patients over 60 years with primary
renal disease. Survival data and clinical results from 242 patients treated
either by haemodialysis or haemofiltration
[PDF]

510

 

 

K Schaefer, G Asmus, E Quellhorst, A Pauls, D von Herrath, J Jahnke

 

 

       
Part XII – GUEST LECTURES ON NEPHROLOGY I    

 

 

 

 

Glomerulonephritis in essential mixed cryoglobulinaemia [PDF]

527

 

 

G D'Amico, F Ferrario, G Colasanti, A Bucci

 

 

       

Effects of various diets on the progression of human and experimental uraemia [PDF]

549

 

 

C Giordano, G Capodicasa, N G De Santo

 

 

     
Part XIII – NEPHROLOGY : DIET AND PROGRESSION OF RENAL DISEASE    

 

 

 

 

Influence of phosphate restriction, keto-acids and vitamin D on the
progression of chronic renal failure
[PDF]

561

 

 

P T Fröhling, R Schmicker, F Kokot, K Vetter, J Kaschube, K-H Götz,
M Jacopian, K Lindenau

 

 

       

Early protein restriction in chronic renal failure [PDF]

567

 

 

J B Rosman, P M ter Wee, G Ph Piers-Becht, W J Sluiter,
F J van der Woude, S Meijer, A J M Donker

 

 

       

Long-term outcome of renal function and proteinuria in kidney transplant donors [PDF]

574

 

 

O Mathillas, P-O Attman, M Aurell, I Blohmé, H Brynger, G Granerus, G Westberg

 

 

       

Renal function and blood pressure after donor nephrectomy [PDF]

580

 

 

J S Tapson, S M Marshall, S R Tisdall, R Wilkinson, M K Ward, D N S Kerr

 

 

       

Part XIV – NEPHROLOGY POSTERS I

 

 

 

 

 

 

Adult-onset nephrotic syndrome with minimal changes: response to
corticosteroids and cyclophosphamide [PDF]

588

 

 

F Nolasco, J Stewart Cameron, J Hicks, C S Ogg, D G Williams

 

 

       

Follow-up prednisolone dosage in rapidly progressive crescentic glomerulonephritis
successfully treated with pulse methylprednisolone or plasma exchange [PDF]

594

 

 

M E Stevens, J M Bone

 

 

       

Effects of dietary protein restriction on the course of early renal failure [PDF]

600

 

 

G Zakar (introduced by I Taraba)

 

 

       

Alteration of the course of chronic renal failure by dietary protein restriction [PDF]

604

 

 

A J Williams, S E Bennett, G I Russell, J Walls

 

 

       

Effects of naloxone infusion on gonadotrophin and prolactin concentrations
in patients with chronic renal failure [PDF]

608

 

 

M Cossu, G B Sorba, M Maioli, P Tomasi, G Delitala

 

 

       

Human pancreatic polypeptide and somatostatin chronic renal failure [PDF]

614

 

 

R Lugari, S David, P Dall'Argine, V Nicolotti, A Parmeggiani, A Gnudi,
A Luciani, S Toscani, R Zandomeneghi

 

 

       
Part XV – GUEST LECTURE ON DIABETIC NEPHROPATHY    

 

 

 

 

Diabetic nephropathy: a preventable complication? [PDF]

621

 

 

C G Viberti, M J Wiseman, J J Bending

 

 

 

 

 

 

Part XVI – DIABETIC NEPHROPATHY

   
     

Urinary excretion of albumin with an altered three-dimensional conformation
in diabetic functional nephropathy. Evidence for a pathogenetic role
[PDF]

633

 

G M Ghiggeri, G Candiano, G Delfino, C Querirolo

 

 

       

Low molecular weight proteinuria in diabetic children - a marker of early
diabetic nephropathy?
[PDF]

638

 

 

R Wartha, D Nebinger, D Gekle

 

 

       

Radionuclear determination of glomerular filtration rate and renal plasma flow
to detect early decrease of renal function in insulin dependent diabetes
[PDF]

642

 

 

C Cascone, G Beltramello, N Borsato, F Cavallin, P Calzavara, M De Luca,
F Susanna, D Madia, P Zanco, B Saitta, M Camerani, G Ferlin

 

 

       

Glycosylated proteins in diabetic nephropathy [PDF]

649

 

 

M Ramzy, M Habib, N El-Sheemy, M Dunn, I Iskander, S Samney, S H Doss

 

 

       

Results of transplantation of kidneys from diabetic donors [PDF]

655

 

 

H van Goor, M J H Slooff, G D Kremer, A M Tegzess

 

 

 

 

 

 

Part XVII – NEPHROLOGY: GLOMERULAR DISEASE    

 

 

 

 

Macrophage function in primary and secondary glomerulonephritis [PDF]

661

 

 

D Roccatello, R Coppo, G Martina, C Rollino, B Basolo, G Picciotto,
F Bayle, P Bajardi, A Amoroso, D Cordonnier, G Piccoli

 

 

       

Interstitial foam cells in the nephrotic syndrome belong to the
monocyte/macrophage lineage [PDF]

666

 

 

F Nolasco, J Stewart Cameron, R Reuben, B Hartley, F Carvalho, R A Coelho

 

 

       

Aetiology and prognosis of de novo graft membranous nephropathy [PDF]

672

 

 

Y Pirson, J Ghysen, J P Cosyns, J P Squifflet, G P J Alexandre,
C van Ypersele de Strihou

 

 

       

Renal involvement in a syndrome of vasculitis complicating HBsAg negative
cirrhosis of the liver [PDF]

677

 

 

J Montoliu, A Darnell, J Mª Grau, A Torras, L Revert

 

 

       

Familial nephropathic amyloidosis associated with indomethacin responsive fever [PDF]

683

 

 

T G Feest, J P Wallis

 

 

       

Immune function and renal transplantation in Fabry's disease [PDF]

686

 

 

D Donati, M G Sabbadini, F Capsoni, L Baratelli, D Cassani,
A De Maio, G Frattini, M Martegani, L Gastaldi

 

 

 

 

 

 

Part XVIII – NEPHROLOGY: GLOMERULAR DISEASE II    

 

 

 

 

Hypertension in mesangial IgA glomerulonephritis [PDF]

693

 

 

M Rambausek, R Waldherr, K Andrassy, E Ritz

 

 

       

Are ß-haemolytic streptococci involved in the pathogenesis of mesangial
IgA-nephropathy?
[PDF]

698

 

 

S Rekola, A Bergstrand, H Bucht, A Lindberg

 

 

       

IgA mesangial deposits in C3H/HeJ mice after oral immunisation [PDF]

703

 

 

C Genin, J C Sabatier, F C Berthoux

 

 

       

The prevention of amyloidosis in Familial Mediterranean fever with colchicine [PDF]

709

 

 

S Calibi, D Zemer, M Pras, A Aviram, E Sohar, J Gafni

 

 

 

 

 

 

Lupus nephritis in males and females [PDF]

712

 

 

I E Tareyeva, T N Janushkevitch, S K Tuganbekova

 

 

 

 

 

 

Filtration fraction: an index of renal disease activity in patients with systemic
lupus erythematosus
[PDF]

717

 

 

H Favre, P A Miescher

 

 

 

 

 

 

Part XIX – NEPHROLOGY POSTER II    

 

 

 

 

The effect of continuous subcutaneous insulin infusion on renal function
in type I diabetic patients with and without proteinuria
[PDF]

722

 

 

E van Ballegooie, P E de Jong, A J M Donker, W J Sluiter

 

 

       

Characterisation of mechanisms responsible for uraemic insulin resistance:
in vitro experiments
[PDF]

725

 

 

O Pedersen, O Schmitz, E Hjøllund, B Richelsen, H E Hansen

 

 

 

 

 

 

Ultrastructural markers of tubular transport in experimental diabetes insipidus [PDF]

732

 

 

L Cieciura, Z Kidawa, B Jaszczuk-Jarosz, K Trznadel, J Konopacki

 

 

 

 

 

 

Distal tubular sodium and water resorption in man [PDF]

738

 

 

E Bartoli, R Faedda, A Satta, M Sanna, G F Branca

 

 
       

High fluid intake or pharmacological therapy in recurrent stone former patients? [PDF]

743

 

 

A Aroldi, G Graziani, P Passerini, C Castelnovo, A Mandressi, A Trinchieri,
G Colussi, C Ponticelli

 

 

       

Magnesium renal wasting in calcium stone formers with idiopathic hypercalciuria
contrasting with lower magnesium: calcium urinary ratio
[PDF]

747

 

 

P Bataille, A Pruna, I Finet, P Leflon, R Makdassi, C Galy, P Fievet, A Fournier

 

 
       

Acute renal failure in an infant with partial deficiency of hypoxanthine-
guanine phosphoribosyltransferase
[PDF]

751

 

 

A-M Winger, W Löffler, R Waldherr, K Schärer

 

 

       

Vitamin D metabolites and osteomalacia in the human Fanconi syndrome [PDF]

756

 

 

G Colussi, Maria Elisabetta De Ferrari, M Surian, F Malberti, G Rombolà,
G Pontoriero, G Galvanini, L Minetti

 

 
       

Effects of acute and chronic ranitidine administration on renal function and
parathyroid activity in chronic renal failure
[PDF]

761

 

 

N Pozet, M Labeeuw, A Hadj Aissa, C Bizolon, P Zech, J Traeger

 

 

       

Cimetidine the H₂-receptor blocker: effect on the renal autoregulation in dogs [PDF]

765

 

 

M A Sobh

 

 

 

 

 

 

Part XX – GUEST LECTURES ON NEPHROLOGY II    

 

 

 

 

Non-invasive assesment of the kidney. What do nuclear medicine,
ultrasonography, digital vascular imaging, computed tomography
and magnetic resonance contribute to diagnosis in nephrology? [PDF]

771

 

 

C van Ypersele de Strihou

 

 

       

Mechanisms and factors regulating the growth of glomerular cells [PDF]

791

 

 

G E Striker, Liliane Morel-Maroger Striker

 

 

 

 

 

 

Part XXI – NEPHROLOGY I    

 

 

 

 

Plasma renin activity, plasma aldosterone and distal urinary acidification
in diabetics with chronic renal failure [PDF]

801

 

 

J Grande, J F Macias, J Miralles, J M Tabernero

 

 

 

 

 

 

Renin angiotensin aldosterone system, urinary prostaglandins and kallikrein
in pregnancy induced hypertension. Evidence for a dis-regulation of the
renin-angiotensin-prostacyclin loop [PDF]

808

 

 

P Fievet, A Fournier, E Agnes, M A Herve, A Carayon, J F de Fremont,
A Mimran, A Dufour, P Verhoest, J C Boulanger

 

 

 

 

 

 

Aldosterone response to modulation of potassium in patients on dialysis
or with essential hypertension
[PDF]

815

 

 

K Olgaard, E Langhoff, E Tvedegaard, S Madsen, M Hammer, H Daugaard,
M Egfjord, J Ladefoged

 

 

 

 

 

 

Role of prostaglandins in captopril-induced natriuresis [PDF]

820

 

 

G Conte, A Dal Canton, G Maglionico, C Di Spigno, B Pirone, D Russo,
G Di Minno, V E Andreucci

 

 

       

Effect of zinc treatment on cell mediated immunity of chronic renal failure patients [PDF]

825

 

 

D Grekas, N Tsakalos, Z Giannopoulos, A Tourkantonis

 

 

 

 

 

 

Adult height in paediatric patients with chronic renal failure [PDF]

830

 

 

G Gilli, K Schärer, O Mehls

 

 

 

 

 

 

Part XXII – NEPHROLOGY: EXPERIMENTAL    

 

 

 

 

Acute renal failure and tubular damage due to sepsis in an animal model [PDF]

837

 

 

A L Linton, J F Walker, R M Lindsay, W J Sibbald

 

 

 

 

 

 

The effects of d-propranolol and captopril on post-ischaemic acute renal
failure in rats [PDF]

843

 

 

M Ishigami, T Maeda, S Yabuki, N T Stowe

 

 

 

 

 

 

Cyclosporine and short ischaemia: a new model of experimental acute renal
failure in rats [PDF]

849

 

 

A Iaina, D Herzog, D Cohen, S Gavendo, S Kapuler, I Serban, G Schiby, H E Eliahou

 

 

 

 

 

 

Glomerulotubular function in cyclosporine-treated rats. A lithium clearance,
occlusion time/transit time and micropuncture study
[PDF]

853

 

 

H Dieperink, H Starklint, P P Leyssac, E Kemp

 

 

       

Unilateral ureteric ligation in diabetic rats: a pathologic and morphometric study [PDF]

860

 

 

G Hatzigeorgiou, P N Ziroyanis, H Paraskevakou, P Vardas, C Georgilis, M Mavrikakis

 

 

       
Part XXIII – NEPHROLOGY II    

 

 

 

 

Reversible tubular dysfunction in alcohol abuse [PDF]

866

 

 

S De Marchi, E Cecchin, F Grimaldi, A Basile, L Dell'Anna, F Tesio

 

 

 

 

 

 

Tubular function and renal selectivity towards glycosyl-albumin in diabetic
hyperosmolar states [PDF]

875

 

 

G Delfino, G Candiano, G M Ghiggeri, C Querirolo

 

 

 

 

 

 

Intracellular bicarbonate and pH of skeletal muscle in chronic renal failure [PDF]

881

 

 

A Guariglia, C Antonucci, E Coffrini, S Del Canale, E Fiaccadori, F Reni,
P Vitali, U Arduini, A Borghetti

 

 

 

 

 

 

Ectopic calcification. The role of parathyroid hormone [PDF]

888

 

 

A M De Francisco, M J D Cassidy, J P Owen, H A Ellis, J R Farndon,
M K Ward, D N S Kerr

 

 

       

Ultrasonically guided fine-needle alcohol injection as an adjunct to medical
treatment in secondary hyperparathyroidism
[PDF]

895

 

 

A Giangrande, P Cantù, L Solbiati, C Ravetto

 

 

       

Low incidence of hyperparathyroidism in diabetic renal failure [PDF]

902

 

 

J Aubia, J Bosch, J Lloveras, Ll Mariñoso, J Masramon, S Serrano,
X Cuevas, A Orfelia, I Llorach, M Llorach

 

 

       
Part XXIV – GUEST LECTURE ON TRANSPANTATION I    
     

Studies on living related kidney donors at a single institution [PDF]

911

 

 

J S Najarian, D Weiland, Blanch Chavers, R L Simmons, W D Payne,
Nancy L Ascher, D E R Sutherland

 

 

       
Part XXV – TRANSPLANTATION POSTERS I    
     

Transfusion-induced enhancement of prostaglandin and thromboxane release
in prospective kidney graft recipients
[PDF]

923

 

 

V Lenhard, G Maassen, G Opelz

 

 

       

Polycythaemia is erythropoietin-independent after renal transplantation [PDF]

928

 

 

S Lamperi, S Carozzi, A Icardi

 

 

     

Kidney transplantation in patients on continuous ambulatory peritoneal dialysis [PDF]

932

 

 

Z Shaphira, D Shmueli, A Yussim, G Boner, C Haimovitz, C Servadio

 

 

       

Pneumatosis intestinalis in patients after cadaveric kidney transplantation:
possible relationship with an active cytomegalovirus infection
[PDF]

936

 

 

W J van Son, F J van der Woude, E J van der Jagt, A J M Donker,
S Meijer, M J H Slooff, T H The, A M Tegzess, L B van der Slikke

 

 

       

Impaired fibrinolysis after kidney transplantation [PDF]

941

 

 

R Seitz, R Michalik, R Egbring, H E Karges, H Lange

 

 

       
Part XXVI – GUEST LECTURE ON TRANSPLANTATION II    

 

 

 

 

Rejection and nephrotoxicity. Diagnostic problems with cyclosporine in
renal transplantation [PDF]

947

 

 

R Pichlmayr, K Wonigeit, B Ringe, T Block, R Raab, B Heigel, P Neuhaus

 

 

       
Part XXVII – TRANSPLANTATION: CYCLOSPORINE    

 

 

 

 

Clinical results and cyclosporine effect on prednisolone metabolism of
cadaver kidney transplanted patients [PDF]

963

 

 

E Langhoff, S Madsen, K Olgaard, J Ladefoged

 

 

     

Does cyclosporine inhibit renal prostaglandin synthesis? [PDF]

969

 

 

D Adu, C J Lote, J Michael, J H Turney, P McMaster

 

 

       

Cyclosporine nephropathy after heart and heart-lung transplantation [PDF]

973

 

 

J Goldstein, Y Thoua, F Wellens, J L Leclerc, J L Vanherweghem,
P Vereerstraeten, G Primo, C Toussaint

 

 

 

 

 

 

Comparison of three immunosuppressive regimens in kidney transplantation:
a single-centre randomised study
[PDF]

982

 

 

M Hourmant, J P Soulillou, J Guenel

 

 

       

Improvement in cyclosporine handling by anti-lymphocyte globulin in the
early post-operative period
[PDF]

987

 

 

R Grundmann, P Wienand, U Hesse

 

 

       
Part XXVIII – TRANSPLANTATION POSTERS    

 

 

 

 

The use of cyclosporine only in cadaveric renal transplant recipients:
conversion to prednisolone and azathioprine after four months [PDF]

992

 

 

A M Tegzess, A J M Donker, S Meijer, W J van Son, F J van Woude,
M J H Slooff, V J Fidler, W J Sluiter, L B van der Slikke

 

 

       

Conversion from cyclosporine to prednisolone and azathioprine.
Safe or unsafe?
[PDF]

998

 

 

D Adu, J Michael, T Vlassis, P McMaster

 

 

       

Does renal failure induce a decrease in cyclosporine blood concentrations? [PDF]

1002

 

 

M Burnier, P Aebischer, J P Wauters, J L Schelling

 

 

       

Increased interleukin II production during kidney allograft rejection [PDF]

1006

 

 

H Vie, M Bonneville, R Cariou, J F Moreau, J P Soulillou

 

 

       

Metabolic effects of conversion from cyclosporine to azathioprine in renal
transplant recipients
[PDF]

1010

 

 

K P G Harris, G I Russell, S P Parvin, P S Veitch, J Walls

 

 

       

Glomerular C3b receptor loss in renal allografts [PDF]

1015

 

 

F Nolasco, B Hartley, R Reuben, K Welsh

 

 

       

Cyclosporine-associated lymphoproliferation, despite controlled cyclosporine
blood concentrations, in a renal allograft recipient
[PDF]

1021

 

 

J B Dossetor, T Kovithavongs, M Salkie, J Preiksaitis

 

 

       

Short-term kidney preservation: to perfuse or not to perfuse with the
new Belzer perfusate [PDF]

1027

 

 

R McCabe, J Lin, K Cooke, M Jean-Jacques

 

 

       

Thromboxane B₂ and ß₂-microglobulin as early indicators of renal allograft rejection [PDF]

1032

 

 

H B Steinhauer, H Wilms, P Schollmeyer

 

 

       

T cell subsets in renal transplanted patients defined by theophylline sensivity
and monoclonal antibodies
[PDF]

1037

 

 

Z Shapira, B Shohat, A Yussim, D Shmueli, C Servadio

 

 

       

Monitoring of NK-1 and NK-15 subsets and natural killer activity in kidney
transplant recipients receiving cyclosporine
[PDF]

1042

 

 

E Renna Molajoni, V Barnaba, A Bachetoni, M Levrero, P Cinti, M Rossi,
D Alfani, R Cortesini

 

 

       

Subject Index [PDF]

1047

 

 

 

 

 

Author Index [PDF]

1061

 

 

In order to open the above PDF files you need Acrobat Reader.

If you do not have it, you can download it here